{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:20:12Z","timestamp":1790202012391,"version":"4.1.0"},"reference-count":70,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Regional Ministry of Health (RMoH)","award":["05\/2010RS"],"award-info":[{"award-number":["05\/2010RS"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Atherosclerotic cardiovascular diseases (ASCVDs) remain the leading cause of morbimortality worldwide. The objectives of this study were to update the prevalence rates of ASCVDs and to evaluate their relationship with cardiovascular\u2013kidney\u2013metabolic (CKM) disorders. Methods: This cross-sectional observational study included 6588 adults selected through a simple random population-based sample from the Health Service database of the Madrid Region (Spain). Adjusted prevalence rates were calculated by the direct method, according to Spanish population data from the National Institute of Statistics. The relationships of CKM disorders with coronary heart disease (CHD), stroke, peripheral arterial disease (PAD), and ASCVD were assessed by bivariate and multivariate analyses. Results: The age- and sex-adjusted prevalence rates among overall adults with CHD, stroke, PAD, and ASCVD were 3.8%, 3.0%, 1.8%, and 7.3%, respectively, and they reached 5.6%, 4.4%, 2.6%, and 10.8%, respectively, among people aged 40 years and older. The prevalence rates were higher in men than women aged over 40 years for CHD and ASCVD, between 50 and 69 years for stroke, and aged over 60 years for PAD. The mean ages of women and men with ASCVD were 74.9 and 70.2 years, respectively. Hypertension, heart failure (HF), hypercholesterolaemia, diabetes, low eGFR, atrial fibrillation (AF), prediabetes, and low HDL-c were independently associated with ASCVD, highlighting hypertension and HF for all of them, in addition to hypercholesterolaemia for CHD and stroke, and specifically, AF for stroke. Conclusions: More than one in ten people aged over 40 suffer from CHD, stroke, or PAD. Hypertension, HF, hypercholesterolaemia, diabetes, and low eGFR are the major CKM disorders associated with ASCVD.<\/jats:p>","DOI":"10.3390\/jcm14113940","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:55:52Z","timestamp":1748951752000},"page":"3940","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["From the Cardiovascular\u2013Kidney\u2013Metabolic Disorders to the Atherosclerotic Cardiovascular Diseases: Their Prevalence Rates and Independent Associations in the SIMETAP Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-5504","authenticated-orcid":false,"given":"Antonio","family":"Ruiz-Garc\u00eda","sequence":"first","affiliation":[{"name":"Lipids and Cardiovascular Prevention Unit, Pinto University Health Centre, 28320 Madrid, Spain"},{"name":"Department of Medicine, European University of Madrid, 28005 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-6078","authenticated-orcid":false,"given":"Vicente","family":"Pallar\u00e9s-Carratal\u00e1","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jaume I University, 12006 Castellon, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalberto","family":"Serrano-Cumplido","sequence":"additional","affiliation":[{"name":"Repelega Health Centre, 48920 Portugalete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pascual-Fuster","sequence":"additional","affiliation":[{"name":"Palleter Health Centre, 12005 Castellon, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-3444","authenticated-orcid":false,"given":"Ezequiel","family":"Arranz-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"San Blas Health Centre, 28981 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5584-4735","authenticated-orcid":false,"given":"Carlos","family":"Escobar-Cervantes","sequence":"additional","affiliation":[{"name":"Department of Cardiology, La Paz University Hospital, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The Heart of the World","volume":"19","author":"Perel","year":"2024","journal-title":"Glob. Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","article-title":"European Society of Cardiology: The 2023 Atlas of Cardiovascular Disease Statistics","volume":"45","author":"Timmis","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Chong, B., Jayabaskaran, J., Jauhari, S.M., Chan, S.P., Goh, R., Kueh, M.T.W., Li, H., Chin, Y.H., Kong, G., and Anand, V.V. (2024). Global burden of cardiovascular diseases: Projections from 2025 to 2050. Eur. J. Prev. Cardiol., zwae281.","DOI":"10.1093\/eurjpc\/zwae281"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1093\/eurheartj\/ehae278","article-title":"Myocardial ischaemic syndromes: A new nomenclature to harmonize evolving international clinical practice guidelines","volume":"45","author":"Boden","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"3238165","article-title":"Stroke in the 21st century: A snapshot of the burden, epidemiology, and quality of life","volume":"2018","author":"Donkor","year":"2018","journal-title":"Stroke Res. Treat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"Writing Committee Members; 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the management of lower extremity peripheral artery disease: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: A Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: A scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation task force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pliquett, R.U. (2022). Cardiorenal syndrome: An updated classification based on clinical hallmarks. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102896"},{"key":"ref_13","first-page":"197","article-title":"Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases","volume":"30","author":"Calle","year":"2018","journal-title":"Clin. Investig. Arterioscler."},{"key":"ref_14","unstructured":"National Center for Health Statistics (NCHS) (2025, May 05). International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), Available online: https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm\/index.html."},{"key":"ref_15","unstructured":"World Health Organization (2025, May 05). International Classification of Primary Care, 2nd edition (ICPC-2). Available online: https:\/\/www.who.int\/standards\/classifications\/other-classifications\/international-classification-of-primary-care."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1037\/a0015808","article-title":"An effect size primer: A guide for clinicians and researchers","volume":"40","author":"Ferguson","year":"2009","journal-title":"Prof. Psychol. Res. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New effect size rules of thumb","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J. Mod. Appl. Stat. Methods"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_19","unstructured":"WHO Consultation on Obesity (2002). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, World Health Organization. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/42330."},{"key":"ref_20","unstructured":"National Institute for Health and Care Excellence (NICE) (2025, May 05). Obesity: Identification, Assessment and Management. Clinical Guideline [CG189]., Available online: www.nice.org.uk\/guidance\/cg189."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/dc11-1334","article-title":"Clinical usefulness of a new equation for estimating body fat","volume":"35","author":"Silva","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Marcos, M.A., G\u00f3mez-S\u00e1nchez, L., Patino-Alonso, M.C., Recio-Rodr\u00edguez, J.I., G\u00f3mez-S\u00e1nchez, M., Rigo, F., Marti, R., Agudo-Conde, C., Maderuelo-Fernandez, J.A., and Ramos, R. (2019). Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study). PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0209992"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_24","first-page":"42","article-title":"Diagnostic performance of lipid accumulation indices and triglyceride and glucose index for metabolic syndrome in a sample of Peruvian adult population","volume":"22","author":"Talavera","year":"2021","journal-title":"Rev. Fac. Med. Hum."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Krakauer, N.Y., and Krakauer, J.C. (2012). A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039504"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/oby.20408","article-title":"Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model","volume":"21","author":"Thomas","year":"2013","journal-title":"Obesity"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kahn, H.S. (2005). The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison. BMC Cardiovasc. Disord., 5.","DOI":"10.1186\/1471-2261-5-26"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"Grundy","year":"2002","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","year":"2008","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., and Tiribelli, C. (2006). The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol., 6.","DOI":"10.1186\/1471-230X-6-33"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology Guidelines for Management of Gout Part I: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_34","first-page":"64","article-title":"AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice","volume":"52","year":"2006","journal-title":"Vnitr. Lek."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yannas, D., Frizza, F., Vignozzi, L., Corona, G., Maggi, M., and Rastrelli, G. (2021). Erectile dysfunction is a hallmark of cardiovascular disease: Unavoidable matter of fact or opportunity to improve men\u2019s health?. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102221"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"ref_40","unstructured":"Centers for Disease Control and Prevention and National Center for Health Statistics (2025, May 05). National Health and Nutrition Examination Survey (NHANES) Public Use Data Files, Available online: https:\/\/www.cdc.gov\/nchs\/nhanes\/."},{"key":"ref_41","unstructured":"GBD 2019 Peripheral Artery Disease Collaborators (2023). Global burden of peripheral artery disease and its risk factors, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob. Health., 11, e1553\u2013e1565."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023 Update: A Report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1253\/circj.CJ-24-0824","article-title":"Association between cardiovascular biological age and cardiovascular disease\u2014A prospective cohort study","volume":"89","author":"Cai","year":"2025","journal-title":"Circ. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.15420\/ecr.2016:32:1","article-title":"Cardiovascular disease in women: Understanding symptoms and risk factors","volume":"12","author":"Sharma","year":"2017","journal-title":"Eur. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Woodward, M. (2019). Cardiovascular disease and the female disadvantage. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16071165"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIR.0b013e3181e8edf1","article-title":"Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: A scientific statement from the American Heart Association","volume":"122","author":"Artinian","year":"2010","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Emerging Risk Factors Collaboration\/EPIC-CVD\/UK Biobank Alcohol Study Group. Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCULATIONAHA.115.014849","article-title":"Primordial Prevention of Cardiovascular Disease","volume":"131","author":"Gillman","year":"2015","journal-title":"Circulation"},{"key":"ref_50","unstructured":"Global Cardiovascular Risk Consortium, Magnussen, C., Alegre-Diaz, J., Al-Nasser, L.A., Amouyel, P., Aviles-Santa, L., Bakker, S.J.L., Ballantyne, C.M., Bernab\u00e9-Ortiz, A., and Bobak, M. (N. Engl. J. Med., 2025). Global effect of cardiovascular risk factors on lifetime estimates, N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1210\/clinem\/dgaa620","article-title":"Association between body size phenotypes and subclinical atherosclerosis","volume":"105","author":"Rossello","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"The Emerging Risk Factors Collaboration, Sarwar, N., Gao, P., Seshasai, S.R., Gobin, R., Kaptoge, S., Di Angelantonio, E., Ingelsson, E., Lawlor, D.A., and Selvin, E. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet, 375, 2215\u20132222.","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar, N., Sandhu, M.S., Ricketts, S.L., Butterworth, A.S., Di Angelantonio, E., Boekholdt, S.M., Ouwehand, W., Watkins, H., and Samani, N.J. (2010). Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies. Lancet, 375, 1634\u20131639.","DOI":"10.1016\/S0140-6736(10)60545-4"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","article-title":"Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: A meta-analysis of cohort studies","volume":"20","author":"Ding","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Theodorakis, N., and Nikolaou, M. (2025). From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: Proposing an expanded framework. Biomolecules, 15.","DOI":"10.3390\/biom15020213"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kimura, Y., Tsukui, D., and Kono, H. (2021). Uric Acid in inflammation and the pathogenesis of atherosclerosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212394"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/21548331.2023.2173413","article-title":"Association of hyperuricemia with cardiovascular diseases: Current evidence","volume":"51","author":"Chrysant","year":"2023","journal-title":"Hosp. Pract."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archinte.167.4.382","article-title":"Subclinical atherosclerosis and risk of atrial fibrillation: The Rotterdam study","volume":"167","author":"Heeringa","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Caturano, A., Galiero, R., Rocco, M., Tagliaferri, G., Piacevole, A., Nilo, D., Di Lorenzo, G., Sardu, C., Russo, V., and Vetrano, E. (2024). The dual burden: Exploring cardiovascular complications in chronic kidney disease. Biomolecules, 14.","DOI":"10.3390\/biom14111393"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.rce.2024.09.004","article-title":"Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study","volume":"225","author":"Mostaza","year":"2025","journal-title":"Rev. Clin. Esp."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"Jankowski","year":"2019","journal-title":"Atherosclerosis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"100985","DOI":"10.1016\/j.ajpc.2025.100985","article-title":"Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: A prospective cohort study","volume":"22","author":"Li","year":"2025","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_70","first-page":"e18","article-title":"Life\u2019s Essential 8: Updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: A presidential advisory from the American Heart Association","volume":"146","author":"Allen","year":"2022","journal-title":"Circulation"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/11\/3940\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:47Z","timestamp":1760032007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/11\/3940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14113940"],"URL":"https:\/\/doi.org\/10.3390\/jcm14113940","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}